Site-1 protease-derived soluble (pro)renin receptor targets vasopressin receptor 2 to enhance urine concentrating capability

JCI Insight. 2019 Apr 4;4(7):e124174. doi: 10.1172/jci.insight.124174.

Abstract

The antidiuretic hormone vasopressin (AVP), acting through its type 2 receptor (V2R) in the collecting duct (CD), critically controls urine concentrating capability. Here, we report that site-1 protease-derived (S1P-derived) soluble (pro)renin receptor (sPRR) participates in regulation of fluid homeostasis via targeting V2R. In cultured inner medullary collecting duct (IMCD) cells, AVP-induced V2R expression was blunted by a PRR antagonist, PRO20; a PRR-neutralizing antibody; or a S1P inhibitor, PF-429242. In parallel, sPRR release was increased by AVP and reduced by PF-429242. Administration of histidine-tagged sPRR, sPRR-His, stimulated V2R expression and also reversed the inhibitory effect of PF-429242 on the expression induced by AVP. PF-429242 treatment in C57/BL6 mice impaired urine concentrating capability, which was rescued by sPRR-His. This observation was recapitulated in mice with renal tubule-specific deletion of S1P. During the pharmacological or genetic manipulation of S1P alone or in combination with sPRR-His, the changes in urine concentration were paralleled with renal expression of V2R and aquaporin-2 (AQP2). Together, these results support that S1P-derived sPRR exerts a key role in determining renal V2R expression and, thus, urine concentrating capability.

Keywords: Nephrology; Transport.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antidiuretic Hormone Receptor Antagonists / pharmacology
  • Aquaporin 2 / genetics
  • Cells, Cultured
  • Epithelial Cells
  • Kidney Concentrating Ability / drug effects
  • Kidney Concentrating Ability / physiology*
  • Kidney Tubules, Collecting / cytology
  • Kidney Tubules, Collecting / drug effects
  • Kidney Tubules, Collecting / metabolism*
  • Male
  • Mice
  • Mice, Knockout
  • Models, Animal
  • Peptide Fragments / pharmacology
  • Primary Cell Culture
  • Proprotein Convertases / antagonists & inhibitors
  • Proprotein Convertases / genetics
  • Proprotein Convertases / metabolism
  • Proton-Translocating ATPases / metabolism*
  • Pyrrolidines / pharmacology
  • Rats
  • Receptors, Cell Surface / metabolism*
  • Receptors, Vasopressin / genetics
  • Receptors, Vasopressin / metabolism*
  • Renin / metabolism
  • Renin / pharmacology
  • Serine Endopeptidases / genetics
  • Serine Endopeptidases / metabolism
  • Urothelium / cytology
  • Vacuolar Proton-Translocating ATPases

Substances

  • ATP6AP2 protein, mouse
  • Antidiuretic Hormone Receptor Antagonists
  • Aqp2 protein, mouse
  • Aquaporin 2
  • Avpr2 protein, mouse
  • Avpr2 protein, rat
  • PF-429242
  • PRO20 peptide
  • Peptide Fragments
  • Pyrrolidines
  • Receptors, Cell Surface
  • Receptors, Vasopressin
  • Proprotein Convertases
  • Serine Endopeptidases
  • membrane-bound transcription factor peptidase, site 1
  • Renin
  • ATP6AP2 protein, rat
  • Vacuolar Proton-Translocating ATPases
  • Proton-Translocating ATPases